OHSU Tech Transfer
OHSU Innovates is a collaborative network supporting research, innovation, and entrepreneurship at Oregon Health & Science University. It aims to advance scientific ideas into real-world solutions through services like technology evaluation, licensing, startup support, collaborations, entrepreneurial education, and funding opportunities. The organization fosters innovation by connecting researchers, clinicians, entrepreneurs, and external partners to improve healthcare and societal outcomes.
Industries
Nr. of Employees
Very Large (1000+)
OHSU Tech Transfer
Products
Technology Disclosure Form (document)
Downloadable form to submit an invention disclosure describing the innovation and contributors for evaluation.
Startup Checklist (document)
Step-by-step checklist outlining suggested stages and tasks for launching a company based on institutional technology.
Biomed Innovation Program (BIP) RFA / Impact reports
Program Request for Applications and annual impact reporting documents that describe funding track details and program outcomes.
Technology Disclosure Form (document)
Downloadable form to submit an invention disclosure describing the innovation and contributors for evaluation.
Startup Checklist (document)
Step-by-step checklist outlining suggested stages and tasks for launching a company based on institutional technology.
Biomed Innovation Program (BIP) RFA / Impact reports
Program Request for Applications and annual impact reporting documents that describe funding track details and program outcomes.
Services
Evaluation, protection, marketing and licensing of institutional inventions and management of license and option negotiation.
One-on-one advising, mentorship, business-plan and commercialization plan assistance, and referrals to incubators and regional resources to support company creation.
Courses and seminar series (I‑Corps style short course, commercialization design reviews, inventor seminars, student competitions) to train researchers and entrepreneurs in commercialization practices.
Administration of gap funding, IDEA Fund seed awards, program-specific funding (Biomed Innovation Program) and travel awards to advance early technologies.
No-cost advisory committee support offering FDA-regulatory advice, clinical protocol feedback, IP guidance and engineering input for drug and device projects.
Access to commercial market intelligence resources and support for competitive landscape and customer discovery research.
Evaluation, protection, marketing and licensing of institutional inventions and management of license and option negotiation.
One-on-one advising, mentorship, business-plan and commercialization plan assistance, and referrals to incubators and regional resources to support company creation.
Courses and seminar series (I‑Corps style short course, commercialization design reviews, inventor seminars, student competitions) to train researchers and entrepreneurs in commercialization practices.
Administration of gap funding, IDEA Fund seed awards, program-specific funding (Biomed Innovation Program) and travel awards to advance early technologies.
No-cost advisory committee support offering FDA-regulatory advice, clinical protocol feedback, IP guidance and engineering input for drug and device projects.
Access to commercial market intelligence resources and support for competitive landscape and customer discovery research.
Expertise Areas
- Technology transfer and commercialization
- Intellectual property assessment and patent strategy
- Startup formation and venture support
- Early-stage funding and gap financing
Key Technologies
- CRISPR gene editing
- Vaccine development
- Gene therapy and viral vector engineering
- Antisense oligonucleotide therapeutics
News & Updates
Delve into advancements in healthcare, startups, and collaborations at OHSU, highlighting innovation metrics and stories in eye care, behavioral health, therapeutics, and cancer detection.
OHSU startup Promedix, co-founded by OHSU professors, won a $200,000 investment for developing a noninvasive device for circulatory dysfunction and sepsis diagnosis.
Technology Commercialization Metrics FY2024
94 invention disclosures, 71 patent applications filed, 77 license agreements, and 89 startups launched since 1998.
Delve into advancements in healthcare, startups, and collaborations at OHSU, highlighting innovation metrics and stories in eye care, behavioral health, therapeutics, and cancer detection.
OHSU startup Promedix, co-founded by OHSU professors, won a $200,000 investment for developing a noninvasive device for circulatory dysfunction and sepsis diagnosis.
Technology Commercialization Metrics FY2024
94 invention disclosures, 71 patent applications filed, 77 license agreements, and 89 startups launched since 1998.